"10.1371_journal.pone.0101044","plos one","2014-07-14T00:00:00Z","Otis C Attucks; Kimberly J Jasmer; Mark Hannink; Jareer Kassis; Zhenping Zhong; Suparna Gupta; Sam F Victory; Mustafa Guzel; Dharma Rao Polisetti; Robert Andrews; Adnan M M Mjalli; Matthew J Kostura","TransTech Pharma LLC, High Point, North Carolina, United States of America; Biochemistry Department and Life Sciences Center, University of Missouri, Columbia, Missouri, United States of America; Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America","Conceived and designed the experiments: OA KJ MH RA SG MG JK DP SV ZZ AM MK. Performed the experiments: OA KJ SG MG JK SV ZZ. Analyzed the data: OA KJ JK ZZ. Contributed reagents/materials/analysis tools: SG MG SV. Wrote the paper: JK MK.","High Point Pharmaceuticals, LLC provided all funds for this work. TransTech Pharma, Inc., TransTech Pharma, LLC, and High Point Pharmaceuticals, LLC are affiliates. The following authors are current or former employees of TransTech Pharma, Inc. or TransTech Pharma, LLC: OA, JK, SG, SV, MG, ZZ, DP, RA, AM, and MK. These current and former employees of TransTech Pharma, Inc., and TransTech Pharma, LLC may own units or unit options in TransTech Pharma, LLC and/or High Point Pharmaceuticals, LLC. High Point Pharmaceuticals, LLC has applied for patents covering some or all of the information disclosed in this manuscript, including but not limited to the molecules, methods of treatment, and screening methods referred to in this manuscript. Two such patent applications are PCT International Application Number PCT/US2011/024311 and PCT International Application Number PCT/US2012/020459. High Point Pharmaceuticals, LLC owns patents covering HPP-4382 and other related compounds that are in development. There are no marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","07","Otis C Attucks","OCA",12,TRUE,12,7,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
